Detalhe da pesquisa
1.
Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis.
Blood
; 135(19): 1696-1703, 2020 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107559
2.
Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry.
Ann Hematol
; 99(7): 1505-1514, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32390114
3.
Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study.
Int J Mol Sci
; 18(4)2017 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28420120
4.
Paroxysmal nocturnal hemoglobinuria: Review of the patient experience and treatment landscape.
Blood Rev
; 64: 101158, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38071133
5.
Transfusion Independence Achieved with Combination Fedratinib and Luspatercept in an Elderly Man with Heavily Pretreated Intermediate-2 Risk Primary Myelofibrosis.
Case Rep Oncol
; 15(1): 126-132, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35350804
6.
Low Rate of Clinically Evident Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with a Complement C5 Inhibitor: Results from a Large, Multicenter, US Real-World Study.
J Blood Med
; 13: 425-437, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35983240
7.
Anagrelide for platelet-directed cytoreduction in polycythemia vera: Insights into utility and safety outcomes from a large multi-center database.
Leuk Res
; 119: 106903, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35717689
8.
An examination of educational gaps in the diagnosis and treatment of myelodysplastic syndromes.
Cancer Control
; 18(1): 65-74, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21273982
9.
Clinical and laboratory features of myelofibrosis and limitations of current therapies.
Clin Adv Hematol Oncol
; 9(9 Suppl 22): 1-16, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22362131
10.
The May-Hegglin anomaly: a rare cause of a common complaint.
BMJ Case Rep
; 14(3)2021 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33649034
11.
A novel patient-reported outcome instrument assessing the symptoms of paroxysmal nocturnal hemoglobinuria, the PNH-SQ.
J Patient Rep Outcomes
; 5(1): 102, 2021 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34581910
12.
Ruxolitinib discontinuation in polycythemia vera: Patient characteristics, outcomes, and salvage strategies from a large multi-institutional database.
Leuk Res
; 109: 106629, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34082375
13.
Paroxysmal nocturnal hemoglobinuria: patient journey and burden of disease.
J Manag Care Spec Pharm
; 26(12-b Suppl): S8-S14, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33356781
14.
Paroxysmal nocturnal hemoglobinuria: role of the complement system, pathogenesis, and pathophysiology.
J Manag Care Spec Pharm
; 26(12-b Suppl): S3-S8, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33356782
15.
Paroxysmal nocturnal hemoglobinuria: current treatments and unmet needs.
J Manag Care Spec Pharm
; 26(12-b Suppl): S14-S20, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33356783
16.
Clinical consequences of iron overload in patients with myelodysplastic syndromes: the case for iron chelation therapy.
Expert Rev Hematol
; 11(7): 577-586, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29902097
17.
RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia.
Nat Commun
; 9(1): 1163, 2018 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29563491
18.
Author Correction: RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia.
Nat Commun
; 9(1): 2286, 2018 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29875356
19.
Phase 2 study of CHOP-R-14 followed by 90Y-ibritumomab tiuxetan in patients with previously untreated diffuse large B-cell lymphoma.
Mol Clin Oncol
; 6(4): 627-633, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28413681
20.
Liver fibrosis and its response to avapritinib in 2 patients with systemic mastocytosis.
Blood Adv
; 6(20): 5630-5633, 2022 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35839085